Merit Medical Systems Inc banner

Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 68.18 USD 5.15% Market Closed
Market Cap: $4.1B

P/FCFE

20.6
Current
33%
Cheaper
vs 3-y average of 30.6

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
20.6
=
Market Cap
$4B
/
Free Cash Flow to Equity
$196.8m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
20.6
=
Market Cap
$4B
/
Free Cash Flow to Equity
$196.8m

Valuation Scenarios

Merit Medical Systems Inc is trading below its 3-year average

If P/FCFE returns to its 3-Year Average (30.6), the stock would be worth $101.34 (49% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+203%
Average Upside
66%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 20.6 $68.18
0%
3-Year Average 30.6 $101.34
+49%
5-Year Average 62.4 $206.63
+203%
Industry Average 21.8 $72.22
+6%
Country Average 21.9 $72.38
+6%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

In line with most companies in the United States of America
Percentile
47th
Based on 7 576 companies
47th percentile
20.6
Low
0 — 13.1
Typical Range
13.1 — 36.5
High
36.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.1
Median 21.9
70th Percentile 36.5
Max 3 188 432.5

Merit Medical Systems Inc
Glance View

Merit Medical Systems Inc. stands as a hallmark of innovation and precision in the medical device industry. Founded in 1987, this Utah-based company has carved a niche by developing and manufacturing a diverse range of products designed to enhance the ability of physicians and improve patient care. Merit's operations focus on the production of disposable medical devices catering primarily to the fields of interventional cardiology, radiology, endoscopy, and pain management. These products, which include a variety of catheters, microcatheters, embolization coils, and other technical components, are crucial in facilitating minimally invasive procedures that speak to the modern medical demand for efficiency and reduced patient recovery times. The company's relentless pursuit of quality and innovation has spurred consistent growth and expanded its presence globally, illustrating its commitment to meeting the evolving needs of healthcare providers and their patients. Revenue streams for Merit Medical Systems derive primarily from the sales of these specialized medical devices, accompanied by an expanding portfolio of customer-driven services and support. Unlike many companies that might get mired in a single product line, Merit has strategically diversified its offerings to spread risk and capture a broader segment of the healthcare market. This diversification is reflected in their investment in research and development, enabling the launch of new products regularly, thereby cushioning the company against the volatility typically seen in the medical device sector. The company’s success is a testament to its ability to maintain close relationships with healthcare providers, listening to and fulfilling their complex needs while operating through an intricate web of direct sales representatives and distribution partners globally. This cohesive model fosters both customer loyalty and drives sustainable business growth, ensuring that Merit Medical Systems remains a pivotal player in the evolving landscape of medical technology.

MMSI Intrinsic Value
79.59 USD
Undervaluation 14%
Intrinsic Value
Price $68.18
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett